fluorodeoxyglucose f18 has been researched along with Salivary Gland Neoplasms in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (6.25) | 18.2507 |
2000's | 10 (31.25) | 29.6817 |
2010's | 17 (53.13) | 24.3611 |
2020's | 3 (9.38) | 2.80 |
Authors | Studies |
---|---|
Broski, SM; Hunt, CH; Johnson, DR; Packard, AT | 1 |
Broglie, MA; Freiberger, SN; Hüllner, MW; Karimian, S; Morand, GB; Rupp, NJ | 1 |
Larson, CR; Wiggins, RH | 1 |
Ho, AL; Krebs, S; Petkovska, I; Ulaner, GA | 1 |
Chikazu, D; Miyamoto, S; Ogawa, T | 1 |
Ho, KC; Hsieh, CE; Hsieh, CH; Liao, CT; Lin, CY; Wang, HM; Yen, TC | 1 |
Cheng, NM; Chou, WC; Chou, YC; Hsieh, CE; Liao, CT; Lin, CY; Venkatesulu, BP; Yen, TC | 1 |
Beppu, S; Hanai, N; Koide, Y; Nishikawa, D; Nishio, M; Suzuki, H; Tamaki, T; Terada, H | 1 |
Cheng, NM; Chou, WC; Fang, YD; Hsieh, CE; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
Asmussen, JT; Bjørndal, K; Diaz, A; Eriksen, JG; Gerke, O; Godballe, C; Høilund-Carlsen, PF; Larsen, SR; Nguyen, N; Nielsen, AL; Nielsen, MK; Rohde, M; Thomassen, A; Westergaard-Nielsen, M | 1 |
Han, Z; Kong, X; Li, H | 1 |
Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Ryu, IS | 1 |
Elnayal, A; Fox, PS; Marom, EM; Mawlawi, O; Moran, CA; Swisher, SG | 1 |
Kubota, K; Makino, T; Nakamura, S; Okochi, K; Shibuya, H; Toriihara, A | 1 |
Alabed, YZ; Laufer, J; Rakheja, R | 1 |
Kim, JS; Kim, SY; Lee, JH; Nam, SY; Oh, JS; Park, MJ; Roh, JL | 1 |
Horiuchi, C; Inoue, T; Ishiguro, Y; Okudera, K; Taguchi, T; Tsukuda, M | 1 |
Nguyen, BD; Roarke, MC | 1 |
Bruce, I; Ghosal, N; Hastings, D; Homer, J; Julyan, P; Mais, K; Ryder, WD; Shenjere, P; Slevin, NJ; Ward, T | 1 |
Ahn, SD; Chang, SK; Choi, EK; Choi, SH; Kim, JH; Kim, JS; Kim, JY; Kim, SS; Kim, SY; Kim, YS; Lee, SW; Nam, SY; Park, JH; Roh, JL; Shin, HS; Song, SY; Yoon, SM | 1 |
Cho, KJ; Choi, SH; Kim, JS; Kim, MJ; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
Bal, C; Faizi, NA; Jain, TK; Kumar, R; Malhotra, A; Sharma, P; Singh, H; Suman, SK | 1 |
Bui, CD; Carlos, RC; Ching, AS; Mukherji, SK; Shreve, PD | 1 |
Graham, MM; Kogame, M; Nishitani, H; Otsuka, H | 1 |
Hicks, RJ; Lau, E; Mac Manus, MP; Ryan, G; Wirth, A | 1 |
Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Ryu, CH | 1 |
Acikgoz, G; Alavi, A; Cermik, TF; Dadparvar, S; Houseni, M; Mavi, A | 1 |
Baek, CH; Choi, JY; Chung, MK; Jeong, HS; Kim, HJ; Ko, YH; Son, YI | 1 |
Han, J; Jeong, SY; Kim, BT; Kim, J; Kim, TS; Lee, KS; Shim, YM | 1 |
Imura, J; Okumura, T; Sato, M; Shioyama, Y | 1 |
Greven, KM; Harkness, BA; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
3 review(s) available for fluorodeoxyglucose f18 and Salivary Gland Neoplasms
Article | Year |
---|---|
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Salivary Gland Neoplasms; Salivary Glands; Tomography, X-Ray Computed | 2022 |
FDG-PET Imaging of Salivary Gland Tumors.
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms; Salivary Glands | 2019 |
The diagnostic role of ultrasonography, computed tomography, magnetic resonance imaging, positron emission tomography/computed tomography, and real-time elastography in the differentiation of benign and malignant salivary gland tumors: a meta-analysis.
Topics: Diagnosis, Differential; Elasticity Imaging Techniques; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2019 |
3 trial(s) available for fluorodeoxyglucose f18 and Salivary Gland Neoplasms
Article | Year |
---|---|
Up-front F18-FDG PET/CT in suspected salivary gland carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Salivary Gland Neoplasms; Young Adult | 2019 |
Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carcinoma, Adenoid Cystic; Cisplatin; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Imatinib Mesylate; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiography, Thoracic; Radiopharmaceuticals; Remission Induction; Salivary Gland Neoplasms; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2011 |
The impact of FDG-PET in the management of patients with salivary gland malignancy.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Salivary Gland Neoplasms; Sensitivity and Specificity | 2005 |
26 other study(ies) available for fluorodeoxyglucose f18 and Salivary Gland Neoplasms
Article | Year |
---|---|
Potential role of hybrid positron emission tomography in pre-operative assessment of primary salivary gland carcinomas.
Topics: Adenoma, Pleomorphic; Carcinoma, Adenoid Cystic; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Salivary Gland Neoplasms; Salivary Glands | 2023 |
Laboratory-Proven Asymptomatic SARS-CoV-2 (COVID-19) Infection on 18F-FDG PET/CT.
Topics: Aged, 80 and over; Betacoronavirus; Coronavirus Infections; COVID-19; Fluorodeoxyglucose F18; Humans; Laboratories; Male; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Salivary Ducts; Salivary Gland Neoplasms; SARS-CoV-2 | 2020 |
Sialadenoma papilliferum in the buccal mucosa detected on
Topics: Adenoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Mucosa; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms | 2017 |
Pretreatment Primary Tumor SUVmax on 18F-FDG PET/CT Images Predicts Outcomes in Patients With Salivary Gland Carcinoma Treated With Definitive Intensity-Modulated Radiation Therapy.
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiotherapy, Intensity-Modulated; Retrospective Studies; Salivary Gland Neoplasms; Treatment Outcome | 2017 |
Pretreatment Primary Tumor and Nodal SUVmax Values on 18F-FDG PET/CT Images Predict Prognosis in Patients With Salivary Gland Carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms | 2018 |
Uptake of
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Salivary Gland Neoplasms; Survival Analysis; Treatment Outcome; Tumor Burden | 2019 |
Prognostic Value of Tumor Heterogeneity and SUVmax of Pretreatment 18F-FDG PET/CT for Salivary Gland Carcinoma With High-Risk Histology.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Salivary Gland Neoplasms | 2019 |
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Salivary Gland Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult | 2013 |
Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Salivary Gland Neoplasms; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed | 2013 |
Can dual-time-point 18F-FDG PET/CT differentiate malignant salivary gland tumors from benign tumors?
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Radiography; Radiopharmaceuticals; Retrospective Studies; Salivary Gland Neoplasms | 2013 |
Solitary extramedullary plasmacytoma of the parotid gland imaged with 18F-FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Parotid Gland; Plasmacytoma; Positron-Emission Tomography; Salivary Gland Neoplasms; Tomography, X-Ray Computed | 2014 |
18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas.
Topics: Adenoma, Pleomorphic; Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Salivary Gland Neoplasms; Sensitivity and Specificity; Statistics as Topic; Young Adult | 2008 |
Salivary duct carcinoma with perineural spread to facial canal: F-18 FDG PET/CT detection.
Topics: Carcinoma, Ductal; Facial Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peripheral Nerves; Positron-Emission Tomography; Salivary Gland Neoplasms; Tomography, X-Ray Computed | 2008 |
Diagnostic value of neck node status using 18F-FDG PET for salivary duct carcinoma of the major salivary glands.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Ducts; Salivary Gland Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck Dissection; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Salivary Gland Neoplasms; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2013 |
Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Parotid Gland; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Salivary Gland Neoplasms; Sublingual Gland; Submandibular Gland; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Diagnostic accuracy of 2-[fluorine-18]fluro-2-deoxy-D-glucose positron emission tomography imaging in nonsquamous tumors of the head and neck.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Papillary; Child; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Salivary Gland Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Positron emission tomography of stage IV mucosa-associated lymphoid tissue lymphoma confined to the four major salivary glands.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms | 2007 |
Clinical utility of 18F-FDG PET for patients with salivary gland malignancies.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Salivary Gland Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
FDG PET in detecting primary and recurrent malignant salivary gland tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Salivary Gland Neoplasms; Sensitivity and Specificity | 2007 |
Role of 18F-FDG PET/CT in management of high-grade salivary gland malignancies.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Salivary Gland Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Integrated PET/CT of salivary gland type carcinoma of the lung in 12 patients.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2007 |
Extrapancreatic F-18 FDG accumulation in autoimmune pancreatitis.
Topics: Aged; Autoimmune Diseases; Cholangiopancreatography, Magnetic Resonance; Diagnosis, Differential; Fibrosis; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Immunohistochemistry; Lymphoma; Male; Neoplasm Metastasis; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms; Submandibular Gland; Tomography, X-Ray Computed | 2008 |
Salivary gland tumors: pretherapy evaluation with PET.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Contrast Media; Deoxyglucose; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Salivary Gland Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
FDG PET in head and neck cancer.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Neoplasms, Unknown Primary; Radiopharmaceuticals; Salivary Gland Neoplasms; Tomography, Emission-Computed | 1997 |